טוען...
Efficacy of metronomic vinorelbine in elderly patients with advanced non-small-cell lung cancer and poor performance status
BACKGROUND: Metronomic chemotherapy—administration of low-dose chemotherapy—allows for a prolonged treatment duration and minimizes toxicity for unfit patients diagnosed with advanced non-small-cell lung cancer (nsclc). METHODS: Oral metronomic vinorelbine at 30 mg thrice weekly was given to 35 chem...
שמור ב:
| הוצא לאור ב: | Curr Oncol |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Multimed Inc.
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5486392/ https://ncbi.nlm.nih.gov/pubmed/28680287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.24.3486 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|